	Evaluation of Optical Coherence Tomography for Metastatic Lymph Node Identification in Canine Oral Malignant Melanoma. Vet Comp Oncol Shen YF, Lapsley JM, Fontes G, Johnson C, Weaver H, Yasenchack J, Orona C, Patel N, Mignucci JS, Jennings R, Selmic LE. PMID: 41461178 [PubMed - as supplied by publisher]
	Cost-Effectiveness of Current Therapeutic Strategies for Melanoma. Curr Treat Options Oncol Goto H. PMID: 41460400 [PubMed - indexed for MEDLINE]
	Revisiting the alpha-synuclein paradox in melanoma-Parkinson's disease connection: more than a tale of two cell fates. Cell Mol Life Sci Aiello J, Zamarato R, Moscheni C, Perrotta C, Clerici M, Trabattoni D, Biasin M, Limanaqi F. PMID: 41460324 [PubMed - indexed for MEDLINE]
	Immuno-oncology approaches to overcome T cell exhaustion in melanoma. Semin Oncol El-Sehrawy AAMA, Alshahrani MY, Fedwi MM, Ganesan S, Al-Khafaji ZA, Arora V, Pal A, Nayak PP, Islomov S, Hsu CY. PMID: 41455351 [PubMed - as supplied by publisher]
	Effectiveness of a stepped-care model to address fear of cancer recurrence in patients with early-stage melanoma: results at 6- and 12-month follow-up. Support Care Cancer Thompson JR, Gomes L, Kouvelis G, Smith AL, Lo SN, Kasparian NA, Saw RPM, Dieng M, Seaman L, Martin LK, Guitera P, Milne D, Schmid H, Cust AE, Bartula I. PMID: 41455003 [PubMed - indexed for MEDLINE]
	A new strategy for melanoma treatment: an investigation of the clinical value of the combination of immune checkpoint inhibitors and oncolytic viruses. Cancer Cell Int Sui B, Jin X, Zheng X. PMID: 41454366 [PubMed - as supplied by publisher]
	Updates in Adjuvant and Neoadjuvant Therapies for Resectable Cutaneous Melanoma. J Am Acad Dermatol Hadfield MJ, Muzumdar S, Sullivan RJ, Katz S, Grant-Kels JM. PMID: 41453433 [PubMed - as supplied by publisher]
	A protocol for development of a microsimulation model platform to evaluate the potential benefits, harms, and cost-effectiveness of risk-tailored melanoma screening. PLoS One McLoughlin KG, Watts CG, Wade S, Smit AK, Soyer HP, Fernandez-Peñas P, Whiteman DC, Guitera P, Reyes-Marcelino G, Canfell K, Cust AE, Caruana M. PMID: 41452872 [PubMed - indexed for MEDLINE]
	Exosomal non-coding RNAs as emerging drivers of immune dysregulation in melanoma. Med Oncol Saeed BI, Kadhum WR, Ullah MI, Mohammed JS, Ballal S, Singh A, Anand DA, Sahoo S, Mustafa YF, Hulail HM. PMID: 41452554 [PubMed - indexed for MEDLINE]
	Exploring medicinal mechanism of baicalin in tumor microenvironment of melanoma via bioinformatic and in vitro study. Med Oncol Liu Z, Dang B, Wang X, Liu Y, Wang C, Lin C. PMID: 41452443 [PubMed - indexed for MEDLINE]
	A 10-year recurrence-free natural course of high-risk stage II cutaneous melanoma: A case report. JPRAS Open Bauer B, Mayrhofer M, Zarfl M, Kamolz LP, Luze H, Nischwitz SP. PMID: 41450449 [PubMed]
	Real-world outcomes of talimogene laherparepvec as salvage therapy for advanced melanoma. J Immunother Cancer Yamada MM, Chandrasekhar S, Gooley TA, Chen RE, Doolittle-Amieva C, Ansstas G, Bhatia S, Hall ET, Nghiem PT, Park SY, Chen DY. PMID: 41448830 [PubMed - indexed for MEDLINE]
	Enhanced overall and progression-free survival in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment - Insights from a multicenter study involving 1296 patients from the prospective skin cancer registry ADOReg. Eur J Cancer Zimmermann N, Kött J, Zell T, Abedini AZ, Blomen CL, Belz S, Deitert B, Heidrich I, Geidel G, Rünger A, Smit DJ, Weichenthal M, Ugurel S, Leiter U, Berking C, Gutzmer R, Schadendorf D, von Wasielewski I, Mohr P, Meier F, Herbst R, Utikal J, Terheyden P, Haferkamp S, Pföhler C, Kaatz M, Ziller F, Ulrich J, Meiss F, Bauer AT, Schneider SW, Gebhardt C. PMID: 41448065 [PubMed - as supplied by publisher]
	New Strategies in Comprehensive Melanoma Treatment: Applications, Potential, and Challenges of Hydrogels. Int J Nanomedicine Jin Q, Lin SQ, Xue XJ, Wang LL, Jiang MY, Wang J, Wu SF, Hu YY. PMID: 41445540 [PubMed - indexed for MEDLINE]
	An in vitro and in silico study focused on the potential modulation of purinergic signaling by rosmarinic acid against cutaneous melanoma. Eur J Pharmacol da Silva GB, Manica D, Ozelame BC, Marcolin M, Stormowski V, Bagatini MD, Kempka AP. PMID: 41443363 [PubMed - as supplied by publisher]
	Should Fertility Preservation Be Offered to Young Women with Melanoma Receiving Immune Checkpoint Inhibitors? A SWOT Analysis. Curr Oncol Raimondo D, Miscia M, Raffone A, Maletta M, Cipriani L, Marchese PV, Comito F, Vicenti R, Cortese F, Pazzaglia E, Bertoldo L, Cobellis L, Seracchioli R. PMID: 41440230 [PubMed - indexed for MEDLINE]
	Endoresection in Choroidal Melanoma: Outcomes of Intentional Incomplete Tumor Removal. Curr Oncol Anduaga-Beramendi A, Caminal-Caramés M, Lorenzo D, Cobos E, Mateos-Olivares M, Garcia-Bru P, Morwani R, Santamaría J, Garcia-Garcia O, Arias L, Caminal JM. PMID: 41440216 [PubMed - indexed for MEDLINE]
	Attention-Based Multimodal Deep Learning for Uveal Melanoma Classification Using Ultra-Widefield Fundus Images and Ocular Ultrasound. Ophthalmol Sci Dadzie AK, Iddir SP, Abtahi M, Ebrahimi B, Rahimi M, Ganesh S, Son T, Heiferman MJ, Yao X. PMID: 41439217 [PubMed]
	Cytotoxicity and apoptotic effects of the ethyl acetate fraction of Zanthoxylum acanthopodium DC fruit on B16F10 melanoma cell culture. Contemp Oncol (Pozn) Megawati ER, Bangun H, Putra IB, Rusda M. PMID: 41438810 [PubMed]
	Towards evidence-based policy in melanoma screening and skin self-examination education. J Eur Acad Dermatol Venereol Ozdemir SO, Shourick J. PMID: 41431948 [PubMed - in process]

Articles 1 - 20 / 44726

Page 1 of 2237



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy